Trial intelligence / Profile preview

CPP-ACP With Fluorides for Tooth Sensitivity After Bleaching

NCT07506850Completed

Sponsor
Universidade Federal do Pará
Start
Feb 2025
Primary completion
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, triple-blind trial of casein phosphopeptide-amorphous calcium phosphate in dentin hypersensitivity (DH) (3 arms), sponsored by Universidade Federal do Pará. Primary endpoint: Tooth Sensitivity. Started Feb 2025; status: completed.

02

Drugs

casein phosphopeptide-amorphous calcium phosphate
03

Conditions

dentin hypersensitivity (DH)

Beyond the preview

Go deeper on NCT07506850.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07506850.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call